paper.io

agar io

wowcappadocia.com cappadocia tours
cappadocia-hotels.com cappadocia hotels
caruscappadocia.com cappadocia hotel
brothersballoon.com cappadocia balloon
balloon-rides.net cappadocia balloon flights

wormax io

rolex replica

Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats

Abstract

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz

Background:Diabetes mellitus (DM) is the most common of the endocrine disorders. Despite of the advance in diabetic treatment, many patients seek alternative options due to various reasons.Complementary and alternative medicine (CAM) has gained popularity because of the possibilities it offers to patients. Gliclazide belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin. Ginger is a potential phytomedicine for the treatment of diabetes through its effects on the activities of glycolytic enzymes. Aim of the work:To study the pharmacodynamics of Ginger compared with that of gliclazide on diabetic rats. Materials and methods:This study was carried on 50 Male adult albino rats (200-250g). They were divided into 2 groups. Group 1 included “10 rats” served as “Control group” received single i.v. injection of citrate buffer, in a volume equal to that used as a solvent for streptozotocin (STZ) used to induce diabetes in test groups. Group 2 included diabetic rats “40 rats” which were injected by single intraperitoneal injection of a freshly prepared solution of STZ in a dose of 55 mg/kg body weight.The diabetic rats were divided into 4 subgroups. Group A “Diabetic rats concurrently treated with saline”. After STZ injection, rats were received 10% (wt/vol) of glucose in the drinking water for 3 days. After that, rats of this group were treated orally by saline for 6 weeks. Group B “Diabetic rats concurrently treated with gliclazide”. After STZ injection, rats were received 10% (wt/vol) of glucose in the drinking water for 3 days. After that, rats of this group were treated orally by 0.3 mg/kg of gliclazide daily for 6 weeks. Group C “Diabetic rats concurrently treated with ginger” After STZ injection, rats were received 10% (wt/vol) of glucose in the drinking water for 3 days. After that, rats of this group were treated orally by (500mg/kg) of ginger daily for 6 weeks. Group D “Diabetic rats concurrently treated with gliclazide and ginger”. After STZ injection, rats were received 10% (wt/vol) of glucose in the drinking water for 3 days. After that, rats of this group were treated orally by (0.3 mg/kg) of gliclazide and (1mL/100g.bw) of ginger daily for 6 weeks.Then blood samples were collected and examined for serum glucose, lipid profile, liver and kidney functions. Rats were sacrificed, livers were obtained and prepared for histological examination. Results: There was statistically significant increase of glucose, triglycerides, low density lipoprotein, total cholesterol, alanine transaminase, aspartate transaminase, urea and creatinine, and significant decrease of high-density lipoprotein in the diabetic group when compared to control group. Administration of either gliclazide or ginger or combination together was associated with improvement of biochemical alterations associated with diabetes with superiority of  A multifaceted review journal in the field of pharmacy 971 Systematic Reviews in Pharmacy Vol 11, Issue 11, Nov-Dec 2020 gliclazide. Histopathological examination revealed that , normal control had normal structure of the liver, while in diabetic group, the liver tissues showed loss of normal lobular architecture, with liver cell apoptosis (the cells are shrunken, the nuclei were dark stained, fragmented or faint). It was revealed that all diabetic treated groups were able to prevent histopathological abnormalities. Conclusion: The present study showed that ginger is a potential phytomedicine for the treatment of diabetes through its effects on the activities of glycolytic enzymes. The combination of Ginger with gliclazide represents a valuable combination to improve diabetes and its complications.

How to Cite this Article
Pubmed Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. SRP. 2020; 11(11): 970-974.
doi:10.31838/srp.2020.11.139

Web Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. http://www.sysrevpharm.org/?mno=18839 [Access: March 29, 2021]. doi:10.31838/srp.2020.11.139

AMA (American Medical Association) Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. SRP. 2020; 11(11): 970-974. doi:10.31838/srp.2020.11.139



Vancouver/ICMJE Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. SRP. (2020), [cited March 29, 2021]; 11(11): 970-974. doi:10.31838/srp.2020.11.139



Harvard Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz (2020) Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. SRP, 11 (11), 970-974. doi:10.31838/srp.2020.11.139



Turabian Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. 2020. Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. Systematic Reviews in Pharmacy, 11 (11), 970-974. doi:10.31838/srp.2020.11.139



Chicago Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. "Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats." Systematic Reviews in Pharmacy 11 (2020), 970-974. doi:10.31838/srp.2020.11.139



MLA (The Modern Language Association) Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz. "Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats." Systematic Reviews in Pharmacy 11.11 (2020), 970-974. Print. doi:10.31838/srp.2020.11.139



APA (American Psychological Association) Style

TAHA AM, TAYEE EM, Abdelkareem E and Taha Azouz (2020) Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats. Systematic Reviews in Pharmacy, 11 (11), 970-974. doi:10.31838/srp.2020.11.139

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3